Skip to main content
Top
Published in: Journal of Cancer Survivorship 4/2012

01-12-2012

Association of bone mineral density with incidental renal stone in long-term survivors of childhood acute lymphoblastic leukemia

Authors: Prasad L. Gawade, Kirsten K. Ness, Shelly Sharma, Zhenghong Li, Deo Kumar Srivastava, Sheri L. Spunt, Kerri Nottage, Matthew J. Krasin, Melissa M. Hudson, Sue C. Kaste

Published in: Journal of Cancer Survivorship | Issue 4/2012

Login to get access

Abstract

Purpose

Our objective was to evaluate the association between low bone mineral density (BMD) and incidental renal stones among long-term survivors of childhood acute lymphoblastic leukemia (ALL).

Methods

Adult participants who were 10+ years from their childhood ALL diagnosis and members of the St. Jude Lifetime Cohort study were recruited between December 2007 and March 2011. During their risk-based medical evaluations, they underwent quantitative computed tomography (QCT) to evaluate BMD. Incidental renal stones were identified by radiologists' review of axial QCT source images. Demographic and dietary information were abstracted from health surveys and the Block Food Frequency questionnaire, respectively. The multivariable logistic regression model was used for analysis.

Results

At a median of 26.1 years from diagnosis, BMD Z scores were ≤−2 in 34 of 662 (5.2 %) and renal stones detected in 73 of 662 (11 %) participants. Adjusted for age, renal radiation, dietary vitamin D, gender, and body mass index, when compared to those with BMD Z scores ≥0, the risk of renal stones was increased among those with BMD Z scores ≤−2 (odds ratio [OR], 2.92; 95 % confidence interval [CI] 1.14–7.48). Risk of renal stones significantly increased for older age (45–54 vs.18–24 years; OR, 3.70; 95 % CI 1.11–12.35) whereas the risk was higher but nonsignificant for >141.5 IU (sample median) daily intake of vitamin D (OR, 1.64; 95 % CI 0.98–2.75).

Conclusions and implications for cancer survivors

Older ALL survivors with BMD Z scores ≤−2 are at risk for renal stones and should be counseled so that appropriate follow-up care can be provided for those among whom renal stones are detected.
Literature
2.
go back to reference Kaste SC. Skeletal toxicities of treatment in children with cancer. Pediatr Blood Cancer. 2008;50:469–73.PubMedCrossRef Kaste SC. Skeletal toxicities of treatment in children with cancer. Pediatr Blood Cancer. 2008;50:469–73.PubMedCrossRef
3.
go back to reference Wasilewski-Masker K, Kaste SC, Hudson MM, Esiashvili N, Mattano LA, Meacham LR. Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature. Pediatrics. 2008;121:e705–13.PubMedCrossRef Wasilewski-Masker K, Kaste SC, Hudson MM, Esiashvili N, Mattano LA, Meacham LR. Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature. Pediatrics. 2008;121:e705–13.PubMedCrossRef
4.
go back to reference Howard SC, Kaplan SD, Razzouk BI, et al. Urolithiasis in pediatric patients with acute lymphoblastic leukemia. Leukemia. 2003;17:541–6.PubMedCrossRef Howard SC, Kaplan SD, Razzouk BI, et al. Urolithiasis in pediatric patients with acute lymphoblastic leukemia. Leukemia. 2003;17:541–6.PubMedCrossRef
5.
go back to reference Jones DP, Spunt SL, Green D, Springate JE. Renal late effects in patients treated for cancer in childhood: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2008;51:724–31.PubMedCrossRef Jones DP, Spunt SL, Green D, Springate JE. Renal late effects in patients treated for cancer in childhood: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2008;51:724–31.PubMedCrossRef
6.
go back to reference Caudarella R, Vescini F, Buffa A, La Manna G, Stefoni S. Osteoporosis and urolithiasis. Urol Int. 2004;72:17–9.PubMedCrossRef Caudarella R, Vescini F, Buffa A, La Manna G, Stefoni S. Osteoporosis and urolithiasis. Urol Int. 2004;72:17–9.PubMedCrossRef
7.
go back to reference Lauderdale DS, Thisted RA, Wen M, Favus MJ. Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner Res. 2001;16:1893–8.PubMedCrossRef Lauderdale DS, Thisted RA, Wen M, Favus MJ. Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner Res. 2001;16:1893–8.PubMedCrossRef
8.
go back to reference Tsuji H, Umekawa T, Kurita T, et al. Analysis of bone mineral density in urolithiasis patients. Int J Urol. 2005;12:335–9.PubMedCrossRef Tsuji H, Umekawa T, Kurita T, et al. Analysis of bone mineral density in urolithiasis patients. Int J Urol. 2005;12:335–9.PubMedCrossRef
9.
go back to reference Letavernier E, Traxer O, Daudon M, et al. Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria. Clin J Am Soc Nephrol. 2011;6:1149–54.PubMedCrossRef Letavernier E, Traxer O, Daudon M, et al. Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria. Clin J Am Soc Nephrol. 2011;6:1149–54.PubMedCrossRef
10.
go back to reference Davies JH, Evans BA, Jenney ME, Gregory JW. Skeletal morbidity in childhood acute lymphoblastic leukaemia. Clin Endocrinol (Oxf). 2005;63:1–9.CrossRef Davies JH, Evans BA, Jenney ME, Gregory JW. Skeletal morbidity in childhood acute lymphoblastic leukaemia. Clin Endocrinol (Oxf). 2005;63:1–9.CrossRef
11.
go back to reference Arjmandi-Rafsanjani K, Hooman N, Vosoug P. Renal function in late survivors of Iranian children with cancer: single centre experience. Indian J Cancer. 2008;45:154–7.PubMedCrossRef Arjmandi-Rafsanjani K, Hooman N, Vosoug P. Renal function in late survivors of Iranian children with cancer: single centre experience. Indian J Cancer. 2008;45:154–7.PubMedCrossRef
12.
go back to reference Kaste SC, Jones-Wallace D, Rose SR, et al. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development. Leukemia. 2001;15:728–34.PubMedCrossRef Kaste SC, Jones-Wallace D, Rose SR, et al. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development. Leukemia. 2001;15:728–34.PubMedCrossRef
13.
go back to reference Pui CH, Roy 3rd S, Noe HN. Urolithiasis in childhood acute leukemia and nonHodgkin's lymphoma. J Urol. 1986;136:1052–4.PubMed Pui CH, Roy 3rd S, Noe HN. Urolithiasis in childhood acute leukemia and nonHodgkin's lymphoma. J Urol. 1986;136:1052–4.PubMed
14.
go back to reference Johri N, Cooper B, Robertson W, Choong S, Rickards D, Unwin R. An update and practical guide to renal stone management. Nephron Clin Pract. 2010;116:c159–71.PubMedCrossRef Johri N, Cooper B, Robertson W, Choong S, Rickards D, Unwin R. An update and practical guide to renal stone management. Nephron Clin Pract. 2010;116:c159–71.PubMedCrossRef
15.
16.
go back to reference Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med. 1992;327:1141–52.PubMedCrossRef Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med. 1992;327:1141–52.PubMedCrossRef
17.
go back to reference Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12:e86–96.PubMed Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12:e86–96.PubMed
18.
go back to reference Lorenz EC, Lieske JC, Vrtiska TJ, et al. Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant. 2011;26:2695–700.PubMedCrossRef Lorenz EC, Lieske JC, Vrtiska TJ, et al. Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant. 2011;26:2695–700.PubMedCrossRef
19.
go back to reference Glowacki LS, Beecroft ML, Cook RJ, Pahl D, Churchill DN. The natural history of asymptomatic urolithiasis. J Urol. 1992;147:319–21.PubMed Glowacki LS, Beecroft ML, Cook RJ, Pahl D, Churchill DN. The natural history of asymptomatic urolithiasis. J Urol. 1992;147:319–21.PubMed
20.
go back to reference Burgher A, Beman M, Holtzman JL, Monga M. Progression of nephrolithiasis: long-term outcomes with observation of asymptomatic calculi. J Endourol. 2004;18:534–9.PubMedCrossRef Burgher A, Beman M, Holtzman JL, Monga M. Progression of nephrolithiasis: long-term outcomes with observation of asymptomatic calculi. J Endourol. 2004;18:534–9.PubMedCrossRef
21.
go back to reference Kaste SC, Thomas NA, Rai SN, et al. Asymptomatic kidney stones in long-term survivors of childhood acute lymphoblastic leukemia. Leukemia. 2009;23:104–8.PubMedCrossRef Kaste SC, Thomas NA, Rai SN, et al. Asymptomatic kidney stones in long-term survivors of childhood acute lymphoblastic leukemia. Leukemia. 2009;23:104–8.PubMedCrossRef
22.
go back to reference Hudson MM, Ness KK, Nolan VG, et al. Prospective medical assessment of adults surviving childhood cancer: study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort study. Pediatr Blood Cancer. 2011;56:825–36.PubMedCrossRef Hudson MM, Ness KK, Nolan VG, et al. Prospective medical assessment of adults surviving childhood cancer: study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort study. Pediatr Blood Cancer. 2011;56:825–36.PubMedCrossRef
23.
go back to reference Kalender WA. Effective dose values in bone mineral measurements by photon absorptiometry and computed tomography. Osteoporos Int. 1992;2:82–7.PubMedCrossRef Kalender WA. Effective dose values in bone mineral measurements by photon absorptiometry and computed tomography. Osteoporos Int. 1992;2:82–7.PubMedCrossRef
24.
go back to reference Cann CE. Low-dose CT, scanning for quantitative spinal mineral analysis. Radiology. 1981;140:813–5.PubMed Cann CE. Low-dose CT, scanning for quantitative spinal mineral analysis. Radiology. 1981;140:813–5.PubMed
25.
go back to reference Cann CE. Quantitative CT, for determination of bone mineral density: a review. Radiology. 1988;166:509–22.PubMed Cann CE. Quantitative CT, for determination of bone mineral density: a review. Radiology. 1988;166:509–22.PubMed
27.
go back to reference Chen YY, Roseman JM, Devivo MJ, Huang CT. Geographic variation and environmental risk factors for the incidence of initial kidney stones in patients with spinal cord injury. J Urol. 2000;164:21–6.PubMedCrossRef Chen YY, Roseman JM, Devivo MJ, Huang CT. Geographic variation and environmental risk factors for the incidence of initial kidney stones in patients with spinal cord injury. J Urol. 2000;164:21–6.PubMedCrossRef
28.
go back to reference Jeong IG, Kang T, Bang JK, et al. Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis. 2011;58:383–8.PubMedCrossRef Jeong IG, Kang T, Bang JK, et al. Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis. 2011;58:383–8.PubMedCrossRef
29.
go back to reference Expert Panel on Detection E, Adults ToHBCi. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.CrossRef Expert Panel on Detection E, Adults ToHBCi. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.CrossRef
30.
go back to reference Boucher B, Cotterchio M, Kreiger N, Nadalin V, Block T, Block G. Validity and reliability of the Block98 food-frequency questionnaire in a sample of Canadian women. Public Health Nutr. 2006;9:84–93.PubMedCrossRef Boucher B, Cotterchio M, Kreiger N, Nadalin V, Block T, Block G. Validity and reliability of the Block98 food-frequency questionnaire in a sample of Canadian women. Public Health Nutr. 2006;9:84–93.PubMedCrossRef
31.
go back to reference Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346:77–84.PubMedCrossRef Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346:77–84.PubMedCrossRef
32.
go back to reference Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol. 2004;15:3225–32.PubMedCrossRef Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol. 2004;15:3225–32.PubMedCrossRef
33.
go back to reference Pearl J. Causal diagrams for empirical research. Biometrika. 1995;82:669–88.CrossRef Pearl J. Causal diagrams for empirical research. Biometrika. 1995;82:669–88.CrossRef
34.
go back to reference Arrabal-Polo MA, Arrabal-Martin M, de Haro-Munoz T, et al. Mineral density and bone remodelling markers in patients with calcium lithiasis. BJU Int. 2011;108:1903–8.PubMedCrossRef Arrabal-Polo MA, Arrabal-Martin M, de Haro-Munoz T, et al. Mineral density and bone remodelling markers in patients with calcium lithiasis. BJU Int. 2011;108:1903–8.PubMedCrossRef
35.
go back to reference Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int. 1998;8:468–89.PubMedCrossRef Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int. 1998;8:468–89.PubMedCrossRef
36.
go back to reference Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, Chabner BA. The pharmacology and clinical use of methotrexate. N Engl J Med. 1983;309:1094–104.PubMedCrossRef Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, Chabner BA. The pharmacology and clinical use of methotrexate. N Engl J Med. 1983;309:1094–104.PubMedCrossRef
37.
go back to reference Abelson HT, Fosburg MT, Beardsley GP, Goorin AM, Gorka C, Link M, et al. Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine. J Clin Oncol. 1983;1:208–16.PubMed Abelson HT, Fosburg MT, Beardsley GP, Goorin AM, Gorka C, Link M, et al. Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine. J Clin Oncol. 1983;1:208–16.PubMed
38.
go back to reference Türk C, Knoll T, Petrik A, Sarica K, Straub M, Seitz C. Guidelines on urolithiasis. Arnhem: European Association of Urology (EAU); 2011. Türk C, Knoll T, Petrik A, Sarica K, Straub M, Seitz C. Guidelines on urolithiasis. Arnhem: European Association of Urology (EAU); 2011.
Metadata
Title
Association of bone mineral density with incidental renal stone in long-term survivors of childhood acute lymphoblastic leukemia
Authors
Prasad L. Gawade
Kirsten K. Ness
Shelly Sharma
Zhenghong Li
Deo Kumar Srivastava
Sheri L. Spunt
Kerri Nottage
Matthew J. Krasin
Melissa M. Hudson
Sue C. Kaste
Publication date
01-12-2012
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 4/2012
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-012-0241-y

Other articles of this Issue 4/2012

Journal of Cancer Survivorship 4/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine